```markdown

Antiamoebic Drugs | Pharmacology - Pikai Pharmacy

1. Summary

This video from Pikai Pharmacy provides a comprehensive overview of antiamoebic drugs, focusing on their pharmacology. It delves into the etiology of amoebiasis, classifies the various antiamoebic agents, and discusses specific drugs used in the treatment of this parasitic infection. The aim is to equip viewers with a solid understanding of how these medications work and which ones are effective.

2. Key Takeaways

* **Amoebiasis is caused by *Entamoeba histolytica***, an intestinal protozoan parasite.

* **Antiamoebic drugs can be broadly classified** based on their target site or mechanism of action.

* **Key drug classes include:**

* **Luminal amoebicides:** Act primarily in the intestinal lumen.

* **Tissue amoebicides:** Effective against amoebae in the tissues.

* **Mixed amoebicides:** Effective against both luminal and tissue forms.

* **Metronidazole is a crucial drug** for treating invasive amoebiasis due to its efficacy against tissue trophozoites.

* **Drugs like Diloxanide furoate and Paromomycin** are important for eradicating luminal cysts.

* **The choice of drug depends on** the location and severity of the amoebic infection (intestinal vs. extraintestinal).

* **Understanding the mechanism of action** is key to appreciating drug efficacy and potential side effects.

3. Detailed Notes

I. Introduction to Amoebiasis

* **Etiology:**

* Caused by *Entamoeba histolytica*, an intestinal protozoan parasite.

* Can exist in two forms:

* **Trophozoite:** Invasive and motile form, responsible for tissue damage.

* **Cyst:** Non-motile, infective form, found in feces.

* **Clinical Manifestations:**

* Asymptomatic carriers (intestinal cysts).

* Intestinal amoebiasis (dysentery, diarrhea).

* Extraintestinal amoebiasis (e.g., amoebic liver abscess, amoebic lung abscess, amoebic brain abscess).

II. Classification of Antiamoebic Drugs

Drugs are classified based on their primary site of action:

* **A. Luminal Amoebicides:**

* Act within the intestinal lumen.

* Primarily used to eradicate residual cysts and trophozoites in the colon lumen, especially after treatment for invasive disease or for asymptomatic cyst passers.

* Examples:

* Diloxanide furoate

* Paromomycin (an aminoglycoside antibiotic with antiamoebic properties)

* Iodoquinol

* Phthalylsulfathiazole (a sulfonamide, less commonly used now)

* **B. Tissue Amoebicides:**

* Effective against *Entamoeba histolytica* trophozoites that have invaded the intestinal wall and spread to other tissues.

* Crucial for treating invasive amoebiasis.

* Examples:

* Metronidazole (a nitroimidazole)

* Tinidazole (similar to metronidazole)

* Chloroguanide (less common)

* Arsenicals (historical, rarely used due to toxicity)

* **C. Mixed Amoebicides (or Luminal and Tissue Amoebicides):**

* Drugs that possess activity against both luminal and tissue forms of the parasite.

* Often used in a combination therapy approach.

* Examples:

* Metronidazole (when used for invasive disease, it also affects luminal forms)

* Tinidazole

III. Specific Antiamoebic Drugs and Their Pharmacology

* **Metronidazole:**

* **Class:** Nitroimidazole.

* **Mechanism of Action:**

* Prodrug that enters the amoebic cell.

* Undergoes reduction in anaerobic environments (like those within the amoebae) to form reactive nitro radical ions.

* These radicals interact with and disrupt DNA synthesis and cause DNA strand breakage, leading to cell death.

* **Spectrum:** Highly effective against *Entamoeba histolytica* trophozoites, including those in tissues and the intestinal lumen. Also effective against other anaerobic protozoa (e.g., *Trichomonas vaginalis*, *Giardia lamblia*) and anaerobic bacteria.

* **Uses:**

* All forms of invasive amoebiasis (intestinal and extraintestinal).

* Often followed by a luminal agent for cyst eradication.

* **Adverse Effects:** Nausea, metallic taste, headache, dizziness, peripheral neuropathy (rare with short-term use), disulfiram-like reaction with alcohol.

* **Tinidazole:**

* **Class:** Nitroimidazole.

* **Mechanism of Action:** Similar to metronidazole.

* **Pharmacokinetics:** Longer half-life than metronidazole, allowing for less frequent dosing.

* **Uses:** Similar indications to metronidazole.

* **Adverse Effects:** Similar to metronidazole.

* **Diloxanide Furoate:**

* **Class:** Luminal amoebicide.

* **Mechanism of Action:** Not fully understood, but believed to disrupt amoebic metabolism.

* **Spectrum:** Primarily effective against luminal trophozoites and cysts. Poor activity against invasive disease.

* **Uses:** Treatment of asymptomatic cyst passers and as a follow-up therapy after metronidazole for invasive amoebiasis to clear luminal parasites.

* **Adverse Effects:** Generally well-tolerated, mild gastrointestinal upset, pruritus.

* **Paromomycin:**

* **Class:** Aminoglycoside antibiotic.

* **Mechanism of Action:** Inhibits protein synthesis by binding to the 30S ribosomal subunit.

* **Spectrum:** Poorly absorbed orally, thus acting predominantly in the intestinal lumen. Effective against luminal trophozoites and cysts.

* **Uses:** Treatment of asymptomatic cyst passers, giardiasis, and cryptosporidiosis. Can be used for luminal amoebiasis.

* **Adverse Effects:** Gastrointestinal upset, malabsorption, ototoxicity and nephrotoxicity (less common with oral use due to poor absorption, but can occur with significant absorption or parenteral administration).

* **Iodoquinol (Diiodohydroxyquin):**

* **Class:** Luminal amoebicide.

* **Mechanism of Action:** Not well understood, may interfere with amoebic enzymes.

* **Spectrum:** Primarily active against luminal trophozoites.

* **Uses:** Treatment of asymptomatic cyst passers. Often used in combination with other drugs.

* **Adverse Effects:** Optic neuritis and peripheral neuropathy (especially with prolonged use), gastrointestinal upset.

IV. Treatment Regimens (General Principles)

* **Asymptomatic Cyst Passers:** Treated with luminal amoebicides (e.g., Diloxanide furoate, Paromomycin, Iodoquinol).

* **Intestinal Amoebiasis (Amoebic Dysentery):**

* Initial treatment with a tissue amoebicide (e.g., Metronidazole or Tinidazole) to clear trophozoites from the intestinal wall.

* Followed by a course of a luminal amoebicide to eradicate any remaining cysts and trophozoites in the lumen.

* **Extraintestinal Amoebiasis (e.g., Liver Abscess):**

* Primary treatment with a tissue amoebicide (Metronidazole or Tinidazole).

* Aspiration of abscesses may be necessary in some cases.

* Followed by a luminal amoebicide course to prevent relapse from intestinal carriage.

V. Important Considerations

* **Drug Resistance:** While not as common for *E. histolytica* as in some other parasitic infections, it's a potential concern.

* **Side Effects Management:** Educating patients about potential side effects is important.

* **Public Health:** Sanitation and clean water are crucial for preventing the spread of amoebiasis.

```